Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


Slc1a3-CreERT2 Targeting Vector
(Plasmid #129409)


Item Catalog # Description Quantity Price (USD)
Plasmid 129409 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Total vector size (bp) 11426
  • Vector type
    Mammalian Expression, Mouse Targeting, Cre/Lox
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy


  • Gene/Insert name
    Slc1a3-2A-CreERT2 Targeting Vector
  • Species
    M. musculus (mouse)
  • Entrez Gene
    Slc1a3 (a.k.a. B430115D02Rik, Eaat1, GLAST, GLAST-1, GLU-T, GluT-1, Gmt1, MGluT1)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    Slc1a3-CreERT2 Targeting Vector was a gift from Walker Jackson (Addgene plasmid # 129409 ; ; RRID:Addgene_129409)
  • For your References section:

    Slc1a3-2A-CreERT2 mice reveal unique features of Bergmann glia and augment a growing collection of Cre drivers and effectors in the 129S4 genetic background. Kaczmarczyk L, Reichenbach N, Blank N, Jonson M, Dittrich L, Petzold GC, Jackson WS. Sci Rep. 2021 Mar 8;11(1):5412. doi: 10.1038/s41598-021-84887-2. 10.1038/s41598-021-84887-2 PubMed 33686166